Ivolution Research Journal · Refutation

Round-number crossing continuation versus matched placebo levels

The first completed RTH crossing of a 100-point ES/NQ level has greater net signed 30-minute continuation than an outcome-blind matched first crossing of a 25/50/75 placebo level.

MST-61 · v1·Refuted·Narrative — weak evidence·Microstructure

Cite as: MST-61: Round-number crossing continuation versus matched placebo levels. Ivolution Research Journal.

Publication status

The pre-registered hypothesis was refuted on the governed research record. This publication documents the null rather than presenting an edge.

The abstract and product-safe scope metadata are public. Methodology, falsification, limitations, citations, and governed results for MST-61 are available to Terminal + AI members.

Symbols

ES · NQ

Regimes

Aggregate

Horizons

15 min · 30 min · 60 min

MST-61: Round-number crossing continuation versus matched placebo levels — Ivolution Research Journal